Community-based analysis of stroke prevention and effect of public interventions in atrial fibrillation: results from the ARENA project
Zylla MM, Özdemir B, Hochadel M, Zeymer U, Akin I, Grau A, Schneider S, Alonso A, Waldecker B 10, Süselbeck T, Schwacke H, Haass M, Zahn R, Borggrefe M, Jochen Senges J, Frey N, Thomas D Clin Res Cardiol. 2024 Aug 8. doi: 10.1007/s00392-024-02510-6
PMID: 39115608 DOI: 10.1007/s00392-024-02510-6
Generalized anxiety is a predictor of impaired quality of life in patients with atrial fibrillation: Findings from the prospective observational ARENA study.
Sadlonova M, Salzmann S, Senges J, Celano CM, Huffman JC, Borggrefe M, Akin I, Thomas D, Schwarzbach CJ, Kleemann T, Schneider S, Hochadel M, Süselbeck T, Schwacke H, Alonso A, Haass M, Ladwig KH, Herrmann-Lingen C.
J Psychosom Res. 2023 Nov 8;176:111542. doi: 10.1016/j.jpsychores.2023.111542. PMID: 37977094
Symptom Severity and Health-Related Quality of Life in Patients with Atrial Fibrillation: Findings from the Observational ARENA Study.
Sadlonova M, Senges J, Nagel J, Celano C, Klasen-Max C, Borggrefe M, Akin I, Thomas D, Schwarzbach CJ, Kleeman T, Schneider S, Hochadel M, Süselbeck T, Schwacke H, Alonso A, Haass M, Ladwig KH, Herrmann-Lingen C.
J Clin Med. 2022 Feb 21;11(4):1140. doi: 10.3390/jcm11041140.
PMID: 35207412
Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme.
Prochaska JH, Coldewey M, Göbel S, Keller K, Hendelmeier M, Konstantinides S, Münzel T, Wild PS; thrombEVAL Study Group.
Eur J Prev Cardiol. 2015 May;22(5):622-8. doi: 10.1177/2047487314527852.
PMID: 24685605 Clinical Trial.
Prospective, multi-center evaluation of a silicon carbide coated cobalt chromium bare metal stent for percutaneous coronary interventions: two-year results of the ENERGY Registry.
Erbel R, Eggebrecht H, Roguin A, Schroeder E, Philipp S, Heitzer T, Schwacke H, Ayzenberg O, Serra A, Delarche N, Luchner A, Slagboom T; ENERGY Investigators.
Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):381-7. doi: 10.1016/j.carrev.2014.10.002.
PMID: 25456414
Long-term follow-up of coronary venous bypass graft lesions treated with a new generation drug-eluting stent with bioabsorbable polymer.
Wessely R, Marzocchi A, Schwacke H, Bertel O, Laanmets P, Perisic Z, Toelg R, Jagic N, Elsässer A, Danzi GB.
J Interv Cardiol. 2013 Oct;26(5):425-33. doi: 10.1111/joic.12056. Epub 2013 Aug 20.
PMID: 23962106
TCT-183 ENERGY 1,000 Patient Registry with a Thin Strut Bare Metal Stent with Passive Coating presenting Two Year Data
Roguin A, Slagboom T, Schroder E, Philiipp S, Heitzer T, Schwacke H, Ayzenberg O, Serra A, Delarche N, Erbel R. ENERGY Investigators.
October 2013Journal of the American College of Cardiology 62(18)
62(18)
DOI:10.1016/j.jacc.2013.08.917
Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole.
Safak E, Schmitz D, Konorza T, Wende C, De Ros JO, Schirdewan A; Linox DX Study Investigators.
Pacing Clin Electrophysiol. 2013 Aug;36(8):952-62. doi: 10.1111/pace.12171. Epub 2013 May 21.
PMID: 23692262
Differences in clinical and echocardiographic parameters between paroxysmal and persistent atrial flutter in the AURUM 8 study: targets for prevention of persistent arrhythmia?
Lickfett L, Mittmann-Braun E, Weiss C, Spencker S, Jung W, Haverkamp W, Willems S, Deneke T, Kautzner J, Wiedemann M, Siebels J, Pitschner HF, Hoffmann E, Hindricks G, Zabel M, Vester E, Schwacke H, Leyen JV, Mewis C, Bauer W, Lewalter T.
Pacing Clin Electrophysiol. 2013 Feb;36(2):194-202. doi: 10.1111/pace.12051.
PMID: 23379836
TCT-630 ENERGY 1'000 Subject Registry with a Thin Strut Bare Metal Stent with Passive Coating Presenting one Year MACE Data on Pre-Specified Subgroups
Erbel R, Eggebrecht H, Roguin A, Schroeder E, Philipp S, Heitzer T, Schwacke H, Ayzenberg O, Serra A, Delarche N, Luchner A, Slagboom T; ENERGY Investigators.
October 2012Journal of the American College of Cardiology 60(17)
60(17)
DOI:10.1016/j.jacc.2012.08.667
Qualitätssicherung mit Routinedaten (QSR) in der Kardiologie: Quality Assurance with Hospital Routine Data in Cardiology
Becker A, Perings C, Schwacke H, Kamp T
Interdisciplinary Contributions to Hospital Management: Medicine, Patient Safety and Economics. 02.07.2012 #001
"Largest amplitude ablation" is the optimal approach for typical atrial flutter ablation: a subanalysis from the AURUM 8 study.
Lewalter T, Lickfett L, Weiss C, Mewis C, Spencker S, Jung W, Haverkamp W, Schwacke H, Deneke T, Proff J, Dorwarth U, Bauer W.
J Cardiovasc Electrophysiol. 2012 May;23(5):479-85. doi: 10.1111/j.1540-8167.2011.02252.x.
PMID: 22458432
TCT-199: ENERGY 1'000 Patient Registry with a Thin Strut Bare Metal Stent with Passive Coating Presenting Six Month Follow-Up MACE
Erbel R, Eggebrecht H , Roguin A, Schroeder E , Heitzer T, Philipp S , Ayzenberg O, Schwacke H , Serra A, Slagboom T
JACC. 2011 Nov, 58 (20_Supplement) B53
Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.
Sack S, Wende CM, Nägele H, Katz A, Bauer WR, Barr CS, Malinowski K, Schwacke H, Leyva F, Proff J, Berdyshev S, Paul V.
Eur J Heart Fail. 2011 Sep;13(9):1019-27. doi: 10.1093/eurjhf/hfr089.
PMID: 21852311 Free PMC article.
Gold vs. platinum-iridium tip catheter for cavotricuspid isthmus ablation: the AURUM 8 study.
Lewalter T, Weiss C, Spencker S, Jung W, Haverkamp W, Willems S, Deneke T, Kautzner J, Wiedemann M, Siebels J, Pitschner HF, Hoffmann E, Hindricks G, Zabel M, Vester E, Schwacke H, Mittmann-Braun E, Lickfett L, Hoffmeister S, Proff J, Mewis C, Bauer W; AURUM 8 Study Investigators.
Europace. 2011 Jan;13(1):102-8. doi: 10.1093/europace/euq339.
PMID: 20876601
640 Chronic performance of a left ventricular pacing lead implantable over-the-wire or stylet-driven
Ellery S, Paul V, Prenner G, Tscheliessnigg K, Merkely B, Malinowski K, Kuelschbach M, Hohn E, Schwacke H, Unterberg C
June 2005Europace 7(Supplement_1):147-147
7(Supplement_1):147-147
DOI:10.1016/eupace/7.Supplement_1.147-a
Catheter ablation of chronic atrial fibrillation with noncontact mapping: are continuous linear lesions associated with ablation success?
Seidl K, Schwacke H, Zahn R, Rameken M, Drögemüller A, Senges J.
Pacing Clin Electrophysiol. 2003 Feb;26(2 Pt 1):534-43. doi: 10.1046/j.1460-9592.2003.00091.x.
PMID: 12710311
Noncontact mapping of ectopic atrial tachycardias: different characteristics of isopotential maps and unipolar electrogram.
Seidl K, Schwacke H, Rameken M, Drögemüller A, Beatty G, Senges J.
Pacing Clin Electrophysiol. 2003 Jan;26(1 Pt 1):16-25. doi: 10.1046/j.1460-9592.2003.00145.x.
PMID: 12685135
Embolic events in patients with atrial fibrillation and ineffective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
Seidl K, Rameken M, Drögemüller A, Vater M, Brandt A, Schwacke H, Bergmeier C, Zahn R, Senges J.
J Am Coll Cardiol. 2002 May 1;39(9):1436-42. doi: 10.1016/s0735-1097(02)01785-0.
PMID: 11985904
Long-term outcome of AV node modulation in 387 consecutive patients with AV nodal reentrant tachycardia.
Schwacke H, Brandt A, Rameken M, Vater M, Fischer F, Senges J, Seidl K.
Z Kardiol. 2002 May;91(5):389-95. doi: 10.1007/s00392-002-0792-4.
PMID: 12132285
Biventricular pacing in patients with ICD: how many patients are possible candidates?
Werling C, Weisse U, Siemon G, Kiessling AH, Rameken M, Schwacke H, Saggau W, Senges J, Seidl K.
Thorac Cardiovasc Surg. 2002 Apr;50(2):67-70. doi: 10.1055/s-2002-26702.
PMID: 11981703
Comparison of two different approaches for catheter ablation of persistent atrial fibrillation: pulmonary vein isolation versus left atrial linear lesions
Seidl K, Rameken M, Vater M, Schwacke H, Brandt A, Senges J
JACC. 2002 Mar, 39 (Supplement_1) 119
Elimination of pulmonary vein potentials for catheter ablation of focal atrial fibrillation guided by noncontact mapping: comparison of two different approaches
Seidl K, Rameken M, Vater M, Schwacke H, Brandt A, Senges J
JACC. 2002 Mar, 39 (Supplement_1) 118
Is catheter ablation of hemodynamically unstable ventricular tachycardia feasible using noncontact mapping?
Seidl K, Rameken M, Vater M, Schwacke H, Brandt A, Senges J
JACC. 2002 Mar, 39 (Supplement_1) 98–99
Is noncontact mapping associated with a higher complication rate than conventional mapping in catheter ablation of complex arrhythmias?
Seidl K, Rameken M, Vater M, Schwacke H, Brandt A, Senges J
JACC. 2002 Mar, 39 (Supplement_1) 98
[Initial experience with an implantable loop recorder in patients with unexplained syncope].
Seidl K, Breunung S, Rameken M, Siemon G, Schwacke H, Drögemüller A, Zahn R, Senges J.
Z Kardiol. 2000 Jan;89(1):43-50. doi: 10.1007/s003920050007.
PMID: 10663916
Clinical experience with the implantable atrial defibrillator (atrioverter) in patients with atrial fibrillation. Metrix Investigators.
Seidl K, Jung W, Schwacke H, Wolpert C, Drögemüller A, Spehl S, Schumacher B, Esmailzadeh B, Werling C, Senges J.
Z Kardiol. 1999 Aug;88(8):574-81. doi: 10.1007/s003920050328.
Lead-related complications in 340 patients with an implantable cardiverter/defibrillator.
Schwacke H, Drögemüller A, Siemon G, Werling C, Saggau W, Senges J, Seidl K.
Z Kardiol. 1999 Aug;88(8):559-65. doi: 10.1007/s003920050326.
PMID: 10506392
Stability and quality of the recorded ECG in a new insertable loop recorder
Siemon G., Droegemueller, A., Schwacke H., Rameken M., Senges J., Seidl K. Herzschrittmacher 1999 19(3):137-139+142-144
Nächtliche Atemregulationsstörungen bei Patienten mit ICD: ein zusätzlicher Risikofaktor für das Auftreten ventrikulärer Arrhythmien?
Friedrich, J., A. Schwarz, M. Bangert, H. Schwacke, K. Seidl, J. Senges Pneumologie 11/98, 52, S. 647
Importance of preimplantation procedures in candidates for an implantable atrial defibrillator.
Seidl K, Hauer B, Kirca M, Drögemüller A, Werling C, Schwacke H, Zahn R, Saggau W, Senges J.
J Cardiovasc Electrophysiol. 1998 Aug;9(8 Suppl):S127-31.
PMID: 9727687
07.01.2026